Steve McCairns Joins Expanding PCI Team as UK Director of Operations
News Apr 02, 2014
Packaging Coordinators, Inc. (PCI) has welcomed Steve McCairns as Director of Operations for its UK business.
PCI is a global leader for packaging services, supporting both pharmaceutical and biotech customers in each stage of the development and commercialization of drug products. In addition to packaging services, PCI provides global storage and distribution services for clinical trial materials.
As a global organization, PCI operates four clinical and commercial sites in the UK with eleven facilities in three locations throughout the United States. The UK site recently announced investment in expansion of on-site Cold Chain packaging capabilities.
McCairns joins PCI with a long and distinguished career in pharmaceutical and healthcare operations, firstly with Amersham PLC and since 2004 with GE Healthcare, holding various operations, quality and international project management roles including Site Director of their Gloucester Manufacturing site since 2008.
McCairns is a Lean Six Sigma practitioner having achieved his Black Belt certification and is a graduate of GE’s prestigious Executive Lean Leadership Development Programme which involved leading Kaizen internationally - throughout Europe, US and Asia; as such he has extensive experience of leveraging Lean Manufacturing and applying Six Sigma principles within a cGMP environment.
Holding a Masters degree in Business Administration from the University of Gloucestershire, McCairns is also in the final stages of completing a Doctorate in Business Administration.
“I am delighted to have someone of Steve’s caliber join the PCI management team,” states Sue Miles, Managing Director PCI UK. “His expertise and skill set are significant additions to our global business, and his vision will help transform this business as we look to grow and expand our services in the healthcare market.”
PhoreMost and o2h Discovery Collaborate to Progress First-in-Class Drug Discovery ProgramsNews
PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, announced it has entered into a collaboration with o2h discovery (o2h), an Anglo-Indian medicinal chemistry company that has in-house capability to take drug discovery programmes to the IND filing stage.READ MORE
Sartorius Stedim Biotech and Siemens Sign Automation AgreementNews
Siemens becomes a preferred supplier for automation solutions. Product portfolio of Sartorius Stedim Biotech to feature a globally standardized automation platform in the future.READ MORE
Microbiotica Enters into Microbiome Collaboration with GenentechNews
Strategic collaboration for microbiome biomarker signatures and therapeutic discovery based on Genentech’s inflammatory bowel disease pipeline.READ MORE